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ABSTRACT
Introduction:Tuberculous meningitis (TBM) is the most common and belligerent form of CNS TB.Prompt definitive 
diagnosis of TBM is arduous due to tedious microbiological procedures. This study was conducted to evaluate the 
neuroradiological findings in patients with TBM as a modality forearly diagnoses and predicting prognosis.
Materials and methods: A successive series of 100 patients diagnosed with TBM admitted to the PIMS neurology 
ward were studied between March 2013 and April 2014. Cranial imaging results were obtained by non-contrast 
enhanced CT brain (NECT) and MRI (magnetic resonance imaging) brain with contrast. MRC staging on admission and 
in-hospital mortality were recorded.Results: The mean age was 34.86 ± 1.76 years with a female preponderance 
(55%, 55 out of 100). On admission, 72% were in MRC stages II or III. The in-hospital mortality was 16%. NECT was 
obtained in all the patients and was abnormal in 67% of the patients with hydrocephalus (58%), edema cerebral (24%) 
and infarcts (5%) being the commonestfindings.CT infarct had the highest mortality rate of 60%. MRI was obtained in 
61% of the patients and was abnormal in 88.5% of these cases. Hydrocephalus (61%), tuberculomas (54%), 
leptomeningeal involvement (46%) and infarcts (13%) were the most frequent radiological signs on MRI.  Mortality was 
significantly associated with infarcts but not with tuberculomas.Conclusion: Neuroimaging techniques are a handy 
tool in the early diagnosis of TBM. MRI is particularly helpful in defining findings such as infarcts and tuberculomas and 
in predicting mortality and morbidity.
KEYWORDS: CNS TB; TBM; NECT; MRI brain; prognosis; mortality; MRC staging.
INTRODUCTION 
Tuberculous meningitis (TBM) is the most common yet 
belligerent form of CNS tuberculosis with invasion and 
involvement of the meninges and the underlying brain 
parenchyma.[1] It constitutes 1% of all cases of TB with 
a case fatality rate of almost 100% in untreated cases, 
as the disease is complicated by hydrocephalus, brain 
edema, infarction, tuberculomas and brain abscess, to 
name a few.[2]  The global disease burden has a 
considerable magnitude with approximately 9 million 
affected in 2013 with an estimated mortality of 1.5 
million.[3]   A delay in treatment precludes a precarious 
outcome, as the disease stage at which antimicrobial 
therapy is started is the single most important predictor 
of prognosis.[4] Early and definitive diagnosis of TBM is 
difficult due to the subacute presentation with 
nonspecific clinical manifestations. The diagnosis of 
TBM cannot be confirmed or excluded on the basis of 
clinical findings. Microbiology is time consuming and 
has a low sensitivity in TBM whether it is acid-fast 
bacillus smear or culture.[4,5, 6]Cerebrospinal fluid (CSF) 
biochemistry and cell count is helpful for diagnosis and 
requires clinical correlation.[7]CSF culture for 
mycobacterium tuberculosis remains the gold standard 
for diagnosing CNS TB. However it is a time-consuming 
investigation with poor sensitivity and can be negative 
in 15-75% of cases.[6]    Studies have suggested a 
better yield with serial larger volume taps, which again 
is cumbersome. [8] Neuroimaging studies, both CT scan 
and MRI are of vital importance in the early diagnosis of 
CNS tuberculosis and may prevent excessive morbidity 
and mortality due to treatment delay and subsequent 
neurological sequelae. [9]Contrast enhanced MR 
imaging is generally considered as the modality of 
choice in the assessment of patients with CNS 
tuberculosis. However, its efficacy and utility has not 
been fully evaluated in clinical trials. The specific 
findings of the disease on imaging studies are 
tuberculomas, basal meningitis, meningeal 
enhancement, hydrocephalus, brain abscess, cerebral 
edema, calcification and infarcts. [9-11]These 
characteristic findings can be more accurately 
identified by MRI brain which can be useful for early 
diagnosis, prognosis and also for follow-up.[12-14]  MRI 
brain provides a better view of infratentorial lesions. 
Modalities like diffusion-weighted imaging (DWI) and 
apparent diffusion coefficient (ADC) sequences aid in 
screening the subtle, early cerebral changes of infarcts 
complicating TBM.[15] However, data regarding the 
diagnostic sensitivity and specificity and prognostic 
implications of neuroimaging in TBM are limited. This 
study was carried out to evaluate the diagnostic and 
prognostic value of neuroimaging techniques i.e. CT 
brain and MRI brain in TBM, in terms of predicting 
disease morbidity and mortality.
MATERIALS AND METHODS
This was a single-center, prospective, observational, 
descriptive study conducted via consecutive, 
non-purposeful sampling at the Department of 
Neurology, PIMS hospital, Islamabad over 13 months 
i.e. from 15th March 2013 to 14th April, 2014 after 
approval from the hospital ethical committee. A series 
of 100 patients diagnosed with tuberculous meningitis 
admitted in succession to the neurology ward were 
enrolled without delay. This study was an independent 
project of the department and was not funded by any 
pharmaceutical organization. Informed consent was 
obtained from all patients (and in case of obtunded or 
comatosed patients from their next of kin). Patients 
above the age of 12 years with diagnosis of TB 
meningitis were included in the study. The diagnosis of 
TBM was established on the basis of clinical and lab 
parameters as well as a favorable, therapeutic 
response to antitubercular therapy at 2 weeks. The 
clinical parameters included any two of: fever, 
constitutional symptoms, symptoms and signs of 
meningeal irritation and altered mental state for more 
than 2 weeks. The lab parameter employed in this 
study was a CSF biochemistry and cell count typical of 
TBM i.e. a lymphocytic-predominant pleocytosis 
(100-500 WBCs with lymphocytic-predominance), 
hypoglycorrhachia (<60% of blood glucose) and high 
protein concentration (>45mg/dl).[4]CSF analysis was 
performed using SysmexXN/1000 2013 analyzer. CSF 
acid-fast bacillus smear was performed in all cases but 
wasn’t employed as diagnostic tool. CSF for AFB 
culture was sent for most of the patients but that data 
was not included in this trial as the aim of this study 
was to validate the diagnostic utility of neuroradiology 
and not microbiology. Key exclusion criteria included 
patients with CSF positive for Gram staining or culture 
of other organisms on lab analyses, patients with 
clinical features and CSF typical of pyogenic meningitis 
(predominant neutrophilic leukocytosis) on routine 
examination, patients with CNS malignancy and 
pregnancy. BMRC (British Medical Research Council 
Scale) staging of TBM was done for all patients at the 
time of admission in addition to detailed history and 
examination. MRC was used as the scale to assess 
disease severity and morbidity in this study.
 An urgent NECT brain scan was done before lumbar 
puncture for all the patients on admission and reported 
by radiologist.  An MRI scan of the brain with contrast, 
DWI and ADC sequences was performed during hospital 
stay or on out-patient basis for all the available patients 
and subsequently reported by a radiologist within a 
week. These scans were evaluated for various 
radiological manifestations of TBM like hydrocephalus, 
cerebral edema, infarct and tuberculomas. In-hospital 
outcome in terms of mortality was recorded for all 
patients during 2 weeks of hospital stay. MRC at the 
time of admission and in-hospital mortality were used 
to define prognosis. All patients were treated with 
antitubercular therapy and steroids and monitored for 
clinical improvement.
STATISTICAL ANALYSIS
Data was collected on standard performa and was 
analyzed by using the statistical software SPSS version 
17 (SPSS Inc. Chicago, IL USA). Discrete variables 
were listed as counts or percentages and continuous 
variables were listed as means ± SD. Chi-square test 
was used for univariate analysis of categorical 
variables.Multivariate analysis was done using stepwise 
forward logistic regression. Significance was set at 
p<0.05. Results were expressed in tabulated form or 
graphically.
RESULTS
The baseline characteristics of study population are 
shown in Table I. The mean age was 34.86 ± 1.75 
years ranging from 13 -80 years with a female 
preponderance (55; 55%). The female to male ratio 
was 1.25:1. At the time of admission, 28% were in 
MRC stage I, 58% were in MRC stage II while 14% were 
in stage III. 16% patients expired within 2 weeks of 
hospital stay and 84% survived. The mean age of the 
patients who had expired was 34.87 ± 2.21 years with 
a female preponderance. The baseline characteristics 
andtheirgender based distribution is mentioned in 
Table I
NECT was obtained in all the patients and was 
abnormal in 67%. The most common CT findings were 
hydrocephalus (58%), cerebral edema (24%) and 
infarcts (5%); summarized in Table II.Some patients 
had a combination of the findings. On univariate 
analysis patients with normal CT weremostlyin MRC 
stage 1 or 2 (p= 0.00) whereas those with infarction 
were mostly in stage 3 (p= 0.00). Those with edema 
and hydrocephalus were mostly in stage 2 (p=00 for 
both). Similarly patients with abnormal CT brain had a 
higher mortality as compared to those with a normal 
NECT (p=0.01). CT infarct had the highest mortality 
(60%; p= 0.00) signifying a higher chance of mortality 
with infarct. This was followed by edema (33%; p = 
0.00) and hydrocephalus (24.0%;p= 0.00). 
Multivariate analysis however showed only edema to be 
significantly associated with a higher MRC stage but 
none of the CT findings were significantly associated 
with mortality(p>0.05 for all) (Table II).
MRI was obtained in 61%and was abnormal in 88.5% 
of these cases. MRI brain could not be done in 39% of 
the patients. Amongthese patients, hydrocephalus 
(61%), tuberculomas (54%), leptomeningeal 
enhancement (46%) and infarcts (13%) were the most 
frequent findings; summarized in Table II and illustrated 
in Figure I.Some patients had a combination of the 
findings. On univariate analysis patients with normal 
MRI mostly were in MRC stage 1 or 2 (p= 0.04) 
whereas those with infarction were mostly in stage 2 or 
3 (p= 0.00). Those with leptomeningeal enhancement 
were mostly in stage 2 (p=00). Univariate analysis did 
not reveal hydrocephalus or tuberculomas to have 
significant association with MRC stage (p.0.05 for 
both). Patients with abnormal MRI brain had higher 
mortality as compared to those with a normal MRI 
(p=0.04). MRI infarct had the highest mortality (50%; 
p= 0.00) signifying a higher chance of mortality with 
infarct. This was followed by leptomeningeal 
enhancement (21%; p = 0.03) (Figure II). Multivariate 
analysis however showed none of the findings to be 
significantly associated with a higher MRC stage 
(p>0.05 for all).Multivariate analysis for mortality 
showed infarct to be significantly associated with higher 
chance of death(p=.00) (Table II) (Figure II)
Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
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INTRODUCTION 
Tuberculous meningitis (TBM) is the most common yet 
belligerent form of CNS tuberculosis with invasion and 
involvement of the meninges and the underlying brain 
parenchyma.[1] It constitutes 1% of all cases of TB with 
a case fatality rate of almost 100% in untreated cases, 
as the disease is complicated by hydrocephalus, brain 
edema, infarction, tuberculomas and brain abscess, to 
name a few.[2]  The global disease burden has a 
considerable magnitude with approximately 9 million 
affected in 2013 with an estimated mortality of 1.5 
million.[3]   A delay in treatment precludes a precarious 
outcome, as the disease stage at which antimicrobial 
therapy is started is the single most important predictor 
of prognosis.[4] Early and definitive diagnosis of TBM is 
difficult due to the subacute presentation with 
nonspecific clinical manifestations. The diagnosis of 
TBM cannot be confirmed or excluded on the basis of 
clinical findings. Microbiology is time consuming and 
has a low sensitivity in TBM whether it is acid-fast 
bacillus smear or culture.[4,5, 6]Cerebrospinal fluid (CSF) 
biochemistry and cell count is helpful for diagnosis and 
requires clinical correlation.[7]CSF culture for 
mycobacterium tuberculosis remains the gold standard 
for diagnosing CNS TB. However it is a time-consuming 
investigation with poor sensitivity and can be negative 
in 15-75% of cases.[6]    Studies have suggested a 
better yield with serial larger volume taps, which again 
is cumbersome. [8] Neuroimaging studies, both CT scan 
and MRI are of vital importance in the early diagnosis of 
CNS tuberculosis and may prevent excessive morbidity 
and mortality due to treatment delay and subsequent 
neurological sequelae. [9]Contrast enhanced MR 
imaging is generally considered as the modality of 
choice in the assessment of patients with CNS 
tuberculosis. However, its efficacy and utility has not 
been fully evaluated in clinical trials. The specific 
findings of the disease on imaging studies are 
tuberculomas, basal meningitis, meningeal 
enhancement, hydrocephalus, brain abscess, cerebral 
edema, calcification and infarcts. [9-11]These 
characteristic findings can be more accurately 
identified by MRI brain which can be useful for early 
diagnosis, prognosis and also for follow-up.[12-14]  MRI 
brain provides a better view of infratentorial lesions. 
Modalities like diffusion-weighted imaging (DWI) and 
apparent diffusion coefficient (ADC) sequences aid in 
screening the subtle, early cerebral changes of infarcts 
complicating TBM.[15] However, data regarding the 
diagnostic sensitivity and specificity and prognostic 
implications of neuroimaging in TBM are limited. This 
study was carried out to evaluate the diagnostic and 
prognostic value of neuroimaging techniques i.e. CT 
brain and MRI brain in TBM, in terms of predicting 
disease morbidity and mortality.
MATERIALS AND METHODS
This was a single-center, prospective, observational, 
descriptive study conducted via consecutive, 
non-purposeful sampling at the Department of 
Neurology, PIMS hospital, Islamabad over 13 months 
i.e. from 15th March 2013 to 14th April, 2014 after 
approval from the hospital ethical committee. A series 
of 100 patients diagnosed with tuberculous meningitis 
admitted in succession to the neurology ward were 
enrolled without delay. This study was an independent 
project of the department and was not funded by any 
pharmaceutical organization. Informed consent was 
obtained from all patients (and in case of obtunded or 
comatosed patients from their next of kin). Patients 
above the age of 12 years with diagnosis of TB 
meningitis were included in the study. The diagnosis of 
TBM was established on the basis of clinical and lab 
parameters as well as a favorable, therapeutic 
response to antitubercular therapy at 2 weeks. The 
clinical parameters included any two of: fever, 
constitutional symptoms, symptoms and signs of 
meningeal irritation and altered mental state for more 
than 2 weeks. The lab parameter employed in this 
study was a CSF biochemistry and cell count typical of 
TBM i.e. a lymphocytic-predominant pleocytosis 
(100-500 WBCs with lymphocytic-predominance), 
hypoglycorrhachia (<60% of blood glucose) and high 
protein concentration (>45mg/dl).[4]CSF analysis was 
performed using SysmexXN/1000 2013 analyzer. CSF 
acid-fast bacillus smear was performed in all cases but 
wasn’t employed as diagnostic tool. CSF for AFB 
culture was sent for most of the patients but that data 
was not included in this trial as the aim of this study 
was to validate the diagnostic utility of neuroradiology 
and not microbiology. Key exclusion criteria included 
patients with CSF positive for Gram staining or culture 
of other organisms on lab analyses, patients with 
clinical features and CSF typical of pyogenic meningitis 
(predominant neutrophilic leukocytosis) on routine 
examination, patients with CNS malignancy and 
pregnancy. BMRC (British Medical Research Council 
Scale) staging of TBM was done for all patients at the 
time of admission in addition to detailed history and 
examination. MRC was used as the scale to assess 
disease severity and morbidity in this study.
 An urgent NECT brain scan was done before lumbar 
puncture for all the patients on admission and reported 
by radiologist.  An MRI scan of the brain with contrast, 
DWI and ADC sequences was performed during hospital 
stay or on out-patient basis for all the available patients 
and subsequently reported by a radiologist within a 
week. These scans were evaluated for various 
radiological manifestations of TBM like hydrocephalus, 
cerebral edema, infarct and tuberculomas. In-hospital 
outcome in terms of mortality was recorded for all 
patients during 2 weeks of hospital stay. MRC at the 
time of admission and in-hospital mortality were used 
to define prognosis. All patients were treated with 
antitubercular therapy and steroids and monitored for 
clinical improvement.
STATISTICAL ANALYSIS
Data was collected on standard performa and was 
analyzed by using the statistical software SPSS version 
17 (SPSS Inc. Chicago, IL USA). Discrete variables 
were listed as counts or percentages and continuous 
variables were listed as means ± SD. Chi-square test 
was used for univariate analysis of categorical 
variables.Multivariate analysis was done using stepwise 
forward logistic regression. Significance was set at 
p<0.05. Results were expressed in tabulated form or 
graphically.
RESULTS
The baseline characteristics of study population are 
shown in Table I. The mean age was 34.86 ± 1.75 
years ranging from 13 -80 years with a female 
preponderance (55; 55%). The female to male ratio 
was 1.25:1. At the time of admission, 28% were in 
MRC stage I, 58% were in MRC stage II while 14% were 
in stage III. 16% patients expired within 2 weeks of 
hospital stay and 84% survived. The mean age of the 
patients who had expired was 34.87 ± 2.21 years with 
a female preponderance. The baseline characteristics 
andtheirgender based distribution is mentioned in 
Table I
NECT was obtained in all the patients and was 
abnormal in 67%. The most common CT findings were 
hydrocephalus (58%), cerebral edema (24%) and 
infarcts (5%); summarized in Table II.Some patients 
had a combination of the findings. On univariate 
analysis patients with normal CT weremostlyin MRC 
stage 1 or 2 (p= 0.00) whereas those with infarction 
were mostly in stage 3 (p= 0.00). Those with edema 
and hydrocephalus were mostly in stage 2 (p=00 for 
both). Similarly patients with abnormal CT brain had a 
higher mortality as compared to those with a normal 
NECT (p=0.01). CT infarct had the highest mortality 
(60%; p= 0.00) signifying a higher chance of mortality 
with infarct. This was followed by edema (33%; p = 
0.00) and hydrocephalus (24.0%;p= 0.00). 
Multivariate analysis however showed only edema to be 
significantly associated with a higher MRC stage but 
none of the CT findings were significantly associated 
with mortality(p>0.05 for all) (Table II).
MRI was obtained in 61%and was abnormal in 88.5% 
of these cases. MRI brain could not be done in 39% of 
the patients. Amongthese patients, hydrocephalus 
(61%), tuberculomas (54%), leptomeningeal 
enhancement (46%) and infarcts (13%) were the most 
frequent findings; summarized in Table II and illustrated 
in Figure I.Some patients had a combination of the 
findings. On univariate analysis patients with normal 
MRI mostly were in MRC stage 1 or 2 (p= 0.04) 
whereas those with infarction were mostly in stage 2 or 
3 (p= 0.00). Those with leptomeningeal enhancement 
were mostly in stage 2 (p=00). Univariate analysis did 
not reveal hydrocephalus or tuberculomas to have 
significant association with MRC stage (p.0.05 for 
both). Patients with abnormal MRI brain had higher 
mortality as compared to those with a normal MRI 
(p=0.04). MRI infarct had the highest mortality (50%; 
p= 0.00) signifying a higher chance of mortality with 
infarct. This was followed by leptomeningeal 
enhancement (21%; p = 0.03) (Figure II). Multivariate 
analysis however showed none of the findings to be 
significantly associated with a higher MRC stage 
(p>0.05 for all).Multivariate analysis for mortality 
showed infarct to be significantly associated with higher 
chance of death(p=.00) (Table II) (Figure II)
Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
DISCLAIMER
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INTRODUCTION 
Tuberculous meningitis (TBM) is the most common yet 
belligerent form of CNS tuberculosis with invasion and 
involvement of the meninges and the underlying brain 
parenchyma.[1] It constitutes 1% of all cases of TB with 
a case fatality rate of almost 100% in untreated cases, 
as the disease is complicated by hydrocephalus, brain 
edema, infarction, tuberculomas and brain abscess, to 
name a few.[2]  The global disease burden has a 
considerable magnitude with approximately 9 million 
affected in 2013 with an estimated mortality of 1.5 
million.[3]   A delay in treatment precludes a precarious 
outcome, as the disease stage at which antimicrobial 
therapy is started is the single most important predictor 
of prognosis.[4] Early and definitive diagnosis of TBM is 
difficult due to the subacute presentation with 
nonspecific clinical manifestations. The diagnosis of 
TBM cannot be confirmed or excluded on the basis of 
clinical findings. Microbiology is time consuming and 
has a low sensitivity in TBM whether it is acid-fast 
bacillus smear or culture.[4,5, 6]Cerebrospinal fluid (CSF) 
biochemistry and cell count is helpful for diagnosis and 
requires clinical correlation.[7]CSF culture for 
mycobacterium tuberculosis remains the gold standard 
for diagnosing CNS TB. However it is a time-consuming 
investigation with poor sensitivity and can be negative 
in 15-75% of cases.[6]    Studies have suggested a 
better yield with serial larger volume taps, which again 
is cumbersome. [8] Neuroimaging studies, both CT scan 
and MRI are of vital importance in the early diagnosis of 
CNS tuberculosis and may prevent excessive morbidity 
and mortality due to treatment delay and subsequent 
neurological sequelae. [9]Contrast enhanced MR 
imaging is generally considered as the modality of 
choice in the assessment of patients with CNS 
tuberculosis. However, its efficacy and utility has not 
been fully evaluated in clinical trials. The specific 
findings of the disease on imaging studies are 
tuberculomas, basal meningitis, meningeal 
enhancement, hydrocephalus, brain abscess, cerebral 
edema, calcification and infarcts. [9-11]These 
characteristic findings can be more accurately 
identified by MRI brain which can be useful for early 
diagnosis, prognosis and also for follow-up.[12-14]  MRI 
brain provides a better view of infratentorial lesions. 
Modalities like diffusion-weighted imaging (DWI) and 
apparent diffusion coefficient (ADC) sequences aid in 
screening the subtle, early cerebral changes of infarcts 
complicating TBM.[15] However, data regarding the 
diagnostic sensitivity and specificity and prognostic 
implications of neuroimaging in TBM are limited. This 
study was carried out to evaluate the diagnostic and 
prognostic value of neuroimaging techniques i.e. CT 
brain and MRI brain in TBM, in terms of predicting 
disease morbidity and mortality.
MATERIALS AND METHODS
This was a single-center, prospective, observational, 
descriptive study conducted via consecutive, 
non-purposeful sampling at the Department of 
Neurology, PIMS hospital, Islamabad over 13 months 
i.e. from 15th March 2013 to 14th April, 2014 after 
approval from the hospital ethical committee. A series 
of 100 patients diagnosed with tuberculous meningitis 
admitted in succession to the neurology ward were 
enrolled without delay. This study was an independent 
project of the department and was not funded by any 
pharmaceutical organization. Informed consent was 
obtained from all patients (and in case of obtunded or 
comatosed patients from their next of kin). Patients 
above the age of 12 years with diagnosis of TB 
meningitis were included in the study. The diagnosis of 
TBM was established on the basis of clinical and lab 
parameters as well as a favorable, therapeutic 
response to antitubercular therapy at 2 weeks. The 
clinical parameters included any two of: fever, 
constitutional symptoms, symptoms and signs of 
meningeal irritation and altered mental state for more 
than 2 weeks. The lab parameter employed in this 
study was a CSF biochemistry and cell count typical of 
TBM i.e. a lymphocytic-predominant pleocytosis 
(100-500 WBCs with lymphocytic-predominance), 
hypoglycorrhachia (<60% of blood glucose) and high 
protein concentration (>45mg/dl).[4]CSF analysis was 
performed using SysmexXN/1000 2013 analyzer. CSF 
acid-fast bacillus smear was performed in all cases but 
wasn’t employed as diagnostic tool. CSF for AFB 
culture was sent for most of the patients but that data 
was not included in this trial as the aim of this study 
was to validate the diagnostic utility of neuroradiology 
and not microbiology. Key exclusion criteria included 
patients with CSF positive for Gram staining or culture 
of other organisms on lab analyses, patients with 
clinical features and CSF typical of pyogenic meningitis 
(predominant neutrophilic leukocytosis) on routine 
examination, patients with CNS malignancy and 
pregnancy. BMRC (British Medical Research Council 
Scale) staging of TBM was done for all patients at the 
time of admission in addition to detailed history and 
examination. MRC was used as the scale to assess 
disease severity and morbidity in this study.
 An urgent NECT brain scan was done before lumbar 
puncture for all the patients on admission and reported 
by radiologist.  An MRI scan of the brain with contrast, 
DWI and ADC sequences was performed during hospital 
stay or on out-patient basis for all the available patients 
and subsequently reported by a radiologist within a 
week. These scans were evaluated for various 
radiological manifestations of TBM like hydrocephalus, 
cerebral edema, infarct and tuberculomas. In-hospital 
outcome in terms of mortality was recorded for all 
patients during 2 weeks of hospital stay. MRC at the 
time of admission and in-hospital mortality were used 
to define prognosis. All patients were treated with 
antitubercular therapy and steroids and monitored for 
clinical improvement.
STATISTICAL ANALYSIS
Data was collected on standard performa and was 
analyzed by using the statistical software SPSS version 
17 (SPSS Inc. Chicago, IL USA). Discrete variables 
were listed as counts or percentages and continuous 
variables were listed as means ± SD. Chi-square test 
was used for univariate analysis of categorical 
variables.Multivariate analysis was done using stepwise 
forward logistic regression. Significance was set at 
p<0.05. Results were expressed in tabulated form or 
graphically.
RESULTS
The baseline characteristics of study population are 
shown in Table I. The mean age was 34.86 ± 1.75 
years ranging from 13 -80 years with a female 
preponderance (55; 55%). The female to male ratio 
was 1.25:1. At the time of admission, 28% were in 
MRC stage I, 58% were in MRC stage II while 14% were 
in stage III. 16% patients expired within 2 weeks of 
hospital stay and 84% survived. The mean age of the 
patients who had expired was 34.87 ± 2.21 years with 
a female preponderance. The baseline characteristics 
andtheirgender based distribution is mentioned in 
Table I
NECT was obtained in all the patients and was 
abnormal in 67%. The most common CT findings were 
hydrocephalus (58%), cerebral edema (24%) and 
infarcts (5%); summarized in Table II.Some patients 
had a combination of the findings. On univariate 
analysis patients with normal CT weremostlyin MRC 
stage 1 or 2 (p= 0.00) whereas those with infarction 
were mostly in stage 3 (p= 0.00). Those with edema 
and hydrocephalus were mostly in stage 2 (p=00 for 
both). Similarly patients with abnormal CT brain had a 
higher mortality as compared to those with a normal 
NECT (p=0.01). CT infarct had the highest mortality 
(60%; p= 0.00) signifying a higher chance of mortality 
with infarct. This was followed by edema (33%; p = 
0.00) and hydrocephalus (24.0%;p= 0.00). 
Multivariate analysis however showed only edema to be 
significantly associated with a higher MRC stage but 
none of the CT findings were significantly associated 
with mortality(p>0.05 for all) (Table II).
MRI was obtained in 61%and was abnormal in 88.5% 
of these cases. MRI brain could not be done in 39% of 
the patients. Amongthese patients, hydrocephalus 
(61%), tuberculomas (54%), leptomeningeal 
enhancement (46%) and infarcts (13%) were the most 
frequent findings; summarized in Table II and illustrated 
in Figure I.Some patients had a combination of the 
findings. On univariate analysis patients with normal 
MRI mostly were in MRC stage 1 or 2 (p= 0.04) 
whereas those with infarction were mostly in stage 2 or 
3 (p= 0.00). Those with leptomeningeal enhancement 
were mostly in stage 2 (p=00). Univariate analysis did 
not reveal hydrocephalus or tuberculomas to have 
significant association with MRC stage (p.0.05 for 
both). Patients with abnormal MRI brain had higher 
mortality as compared to those with a normal MRI 
(p=0.04). MRI infarct had the highest mortality (50%; 
p= 0.00) signifying a higher chance of mortality with 
infarct. This was followed by leptomeningeal 
enhancement (21%; p = 0.03) (Figure II). Multivariate 
analysis however showed none of the findings to be 
significantly associated with a higher MRC stage 
(p>0.05 for all).Multivariate analysis for mortality 
showed infarct to be significantly associated with higher 
chance of death(p=.00) (Table II) (Figure II)
 Variables Total n %    Gender Mean ± SD (range)/ n (%)
 Male    Female 
 Mean Age (yrs) 34.86±1.75 39.64±1.90 (16-80)  30.94±1.53 (13-80) 
 MRC Stage MRC I 28 (28) 12 (12) 16 (16)
  MRC II 58 (58) 28 (28) 30 (30)
  MRC III 14 (14) 5 (5) 9 (9)
 Mortality Died 16 (16) 5 (5) 11 (11)
  Survived 84 (84 40 (40) 44 (44)
Table I: Baseline characteristics at admission and gender based distribution
Table II: Univariate and multivariate analysis for CT and MRI brain findings
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Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
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Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
DISCLAIMER
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Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
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Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
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Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
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Figure I: MRI Brain in CNS TB
Figure I:  MRI Brain in CNS TB: A: Hydrocephalus as 
shown in MRI brain of one of our patients (No.22) 
depicted by dilated anterior and posterior horns of 
lateral ventricles (arrow heads),B: DWI MRI Brain 
showing restricted diffusion in right sided basal ganglia 
and thalamus regions in one of our patients (No.35) 
(arrow head in circle), C: Schematic of MRI Brain T1WI 
with contrast studded with multiple small tuberculomas 
(arrow heads)(No.72)D: MRI Brain T1WI with contrast 
showing basal meningeal enhancement (thick arrow 
head within circle) in one of our patients (No.83).
Figure II: MRI Brain findings and distribution of 
mortality: vertical double capped lines show 1 SD.
DISCUSSION
TBM is the most common cause of chronic meningitis 
caused by mycobacterium tuberculosis in the 
developing countries and is a major public health 
problem due to its permanent neurological sequelae 
and mortality. [4] It is the most common and severe form 
of central nervous system tuberculosis with invasion 
and involvement of the meninges and the underlying 
brain parenchyma. The diagnosis of TBM is elusive and 
high index of suspicion is necessary for early diagnoses. 
The definitive diagnosis of TBM is dependent on 
microbiological testing by demonstrating M. 
tuberculosis on smear as AFB or culture of the CSF. 
[16,17]CSF acid fast bacillus has a low sensitivity of 
20-40%.[18]CSF culture is a time-consuming procedure. 
Moreover, CSF culture can be negative in 15-75% of 
cases.[6] Treatment delay is often associated with high 
fatality therefore early recognition is of paramount 
importance as the clinical outcome depends upon the 
stage at which therapy is initiated.[2,17] Current 
antituberculous drugs are highly effective when 
treatment commences early, before the onset of 
complications.The typical neuroradiological findings of 
TBM appear due to the pathophysiology of TBM which 
can aid in the diagnosis of TBM.[19,20]However, the 
diagnostic value hasn’t been fully validated in studies. 
Moreover, data on the utility of neuroradiology in 
predicting the outcome of TBM is even more 
limited.Cranial imaging is useful in diagnosing TBM, 
predicting its complications and also has a prognostic 
value.[14,21-25]  Some studies comparing CT to MRI have 
indicated MRI as a superior diagnostic imaging 
modality.[23-25]  In this study, NECT brain was obtained in 
all the patients prior to lumbar puncture, due to easy 
availability and quick completion. CT brain was 
abnormal in 67% of the patients. In a review of 289 
patients published in the year 2000 CT brain was found 
to be abnormal in 87% cases.[26]  This difference in 
radiological yield may be attributed to the fact that they 
performed both NECT and CT with contrast while we 
only got the former done. MRI brain with contrast with 
DWI and ADC was done in 61% of the patients. Out of 
the 61 patients in whom MRI scans were done 88.5% 
had radiological findings. This finding is almost 
comparable to a study in which MRI brain revealed 
findings in 90% cases.[27]   MRI showed even more 
findings in cases where CT scan results were suspicious 
or normal especially in case of meningeal 
enhancement or tuberculomas as seen in earlier 
studies.[27] In this study 10 patients had normal CT 
scans of the brain, while the MRI scans of these 
patients revealed abnormal findings. MRI with contrast 
has higher efficacy for detecting tuberculomas, basal 
enhancement and infarction in TBM. Majority of the 
patients in this study presented in MRC stage 2 which 
is comparable with most of other studies. [28]The 
delayed presentation of TBM may be attributed to the 
poor socioeconomic background and low literacy rate of 
most of our patients, especially those from remote rural 
areas who do not seek proper medical assistance until 
the terminal stages of the disease. However, this just a 
theoretical assumption and requires proper statistical 
validation. Ischemia/infarcts were observed in 13% of 
the patients. Previous studies reported the incidence of 
infarction in TBM as ranging from 13% to 
53%.[29-31]Those patients who had infarcts on CT or MRI 
brain had greater morbidity reflected by MRC stage of 
mostly 3. Almost 60% mortality was seen in these 
patients. Infarcts have been shown to be associated 
with poor outcome in TBM as shown Wasay et al in their 
study.[14] MR scans especially DWI sequences were 
superior in detecting infarcts. The mean age of patients 
with TBM complicated by infarcts was 35.12 ± 2.18 
years (75% males)  in our study which was much lower 
than the mean of age of similar patients in their study 
i.e. 57 ± 17.6 (56.7% males). They attributed it to 
Ischemic heart disease while we propose an infection 
relatedvasculitis as the etiology which tends to be more 
common in younger patients. This however, needs 
validation in a separate study designed to evaluate 
patients of TBM with infarcts alone.Tuberculomas were 
detected in 33 of the patients in this study (54%). 
Tuberculomas are common forms of CNS TB and result 
from parenchymal rich foci.[10]Tuberculomas are 
frequently multiple. [10,26,27]In this study 82.4% of these 
33 patients had multiple tuberculomas. Patients with 
tuberculomas were mostly in MRC stage 2. However, 
mortality was not statistically significant. This is in 
contrast to older studies;[32] but corresponds to the 
results of the study by Wasay et al.[14] Hydrocephalus is 
a common complication of TBM, and was seen in 61% 
cases in this study which is in accordance with most of 
the other studies.[32,33]The reported frequency of 
hydrocephalus varies from 12% to 77% in patients with 
TBM in various case series.[16,32-34] Patients with 
hydrocephalus were mostly in MRC stage 2 and had a 
higher mortality compared to those with normal 
neuroimaging. In conclusion, patients with infarcts had 
a worse outcome as compared to those with 
hydrocephalus or tuberculomas.MRI scans provided 
additional findings such as tuberculomas and infarcts 
not identified on CT. This might help in modifying drug 
regime or duration of therapy by follow up scans and 
comparing scans for resolution of findings. This study 
was limited by the fact that patients were screened only 
at the commencement of therapy, and there was no set 
protocol for follow up of patients who develop these 
complications during the course of treatment or 
whether initiating prompt therapy conferred a better 
outcome as we did not study end of treatment 
outcomes.  Neuroradiological findings such as infarcts, 
tuberculoma or hydrocephalus, are helpful for the 
diagnosis of TBM in the early stages before a 
microbiological diagnosis is established.[35-37] MRI and 
CT scanning are also critical in predicting the outcome 
and in evaluating the complications of the disease as 
shown in the study by Wasay et al.[14] Therefore, MRI 
brain with contrast and DWI sequences should be 
performed for all patients in the early stage of the 
disease to detect specific signs related with poor 
outcome. It may reveal specific radiological findings 
associated with TBM which contribute to diagnostic 
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early 
diagnosis of TBM. MRI is particularly helpful in defining 
findings such as infarcts and tuberculomas and in 
predicting mortality and morbidity.
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